InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Tardio Jason. Director active across 1 company, notably Ovid Therapeutics Inc.. Cumulatively, 2 filings have been published. Split: 0 buy · 1 sell. Total volume traded: €37k. Activity tracked since 12 September 2022. The latest transaction was filed on 22 February 2024 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations